Encyclopedia of Metagenomics

Living Edition
| Editors: Karen E. Nelson

Human Microbiota and Pathogen-Associated Gastrointestinal Disease

  • Bonnie P. Youmans
  • Nadim J. Ajami
  • Sarah K. Highlander
Living reference work entry
DOI: https://doi.org/10.1007/978-1-4614-6418-1_72-1

Synonyms

Definition

Pathogen-associated diarrhea is defined as the passing of at least three watery or bloody stools within a 24-h period caused by an infectious agent. This overview will focus on common bacterial, parasitic, and viral pathogens that cause diarrhea.

Introduction

Diarrheal diseases affect approximately one billion individuals worldwide each year. The World Health Organization (WHO) estimated that more than two million deaths were caused by diarrheal diseases in 2008. In the USA alone, these illnesses result in greater than $77 billion in annual economic losses (Scharff 2012). Infectious diarrhea is generally transmitted via the fecal-oral route and by ingestion of contaminated food or water. General symptoms can include abdominal pain and cramping, tenesmus, nausea, vomiting, fatigue, and fever. Stools are watery and may contain blood or white cells depending on the etiologic agent.

Many pathogens can cause diarrhea. In about half of...

Keywords

Hemolytic Uremic Syndrome Diarrheal Disease Bloody Diarrhea Shiga Toxin Infectious Diarrhea 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in to check access.

References

  1. Agbor TA, McCormick BA. Salmonella effectors: important players modulating host cell function during infection. Cell Microbiol. 2011;13(12):1858–69.PubMedCentralPubMedCrossRefGoogle Scholar
  2. Atmar RL, Bernstein DI, Harro CD, Al-Ibrahim MS, Chen WH, Ferreira J, et al. Norovirus vaccine against experimental human Norwalk Virus illness. N Engl J Med. 2011;365(23):2178–87.PubMedCentralPubMedCrossRefGoogle Scholar
  3. Ball JM, Graham DY, Opekun AR, Gilger MA, Guerrero RA, Estes MK. Recombinant Norwalk virus-like particles given orally to volunteers: phase I study. Gastroenterology. 1999;117(1):40–8.PubMedCrossRefGoogle Scholar
  4. Bergan J, Dyve Lingelem AB, Simm R, Skotland T, Sandvig K. Shiga toxins. Toxicon. 2012;60(6):1085–107.PubMedCrossRefGoogle Scholar
  5. Clements A, Young JC, Constantinou N, Frankel G. Infection strategies of enteric pathogenic Escherichia coli. Gut Microbes. 2012;3(2):71–87.PubMedCentralPubMedCrossRefGoogle Scholar
  6. Dasti JI, Tareen AM, Lugert R, Zautner AE, Gross U. Campylobacter jejuni: a brief overview on pathogenicity-associated factors and disease-mediating mechanisms. Int J Med Microbiol. 2010;300(4):205–11.PubMedCrossRefGoogle Scholar
  7. Ericsson CD, DuPont HL, Steffen R. Travelers’ diarrhea. 2nd ed. Hamilton: BC Decker; 2008.Google Scholar
  8. Estes MK, Kang G, Zeng CQ, Crawford SE, Ciarlet M. Pathogenesis of rotavirus gastroenteritis. Novartis Found Symp. 2001;238:82–96. discussion -100.PubMedCrossRefGoogle Scholar
  9. Harrington SM, Dudley EG, Nataro JP. Pathogenesis of enteroaggregative Escherichia coli infection. FEMS Microbiol Lett. 2006;254(1):12–8.PubMedCrossRefGoogle Scholar
  10. Jawa RS, Mercer DW. Clostridium difficile-associated infection: a disease of varying severity. Am J Surg. 2012;204(6):836–42.PubMedCrossRefGoogle Scholar
  11. Kapikian AZ. Overview of viral gastroenteritis. Arch Virol Suppl. 1996;12:7–19.PubMedGoogle Scholar
  12. Marteyn B, Gazi A, Sansonetti P. Shigella: a model of virulence regulation in vivo. Gut Microbes. 2012;3(2):104–20.PubMedCentralPubMedCrossRefGoogle Scholar
  13. Mills DC, Gundogdu O, Elmi A, Bajaj-Elliott M, Taylor PW, Wren BW, et al. Increase in Campylobacter jejuni invasion of intestinal epithelial cells under low-oxygen coculture conditions that reflect the in vivo environment. Infect Immun. 2012;80(5):1690–8.PubMedCentralPubMedCrossRefGoogle Scholar
  14. Pawlowski SW, Warren CA, Guerrant R. Diagnosis and treatment of acute or persistent diarrhea. Gastroenterology. 2009;136(6):1874–86.PubMedCentralPubMedCrossRefGoogle Scholar
  15. Scharff RL. Economic burden from health losses due to foodborne illness in the United States. J Food Prot. 2012;75(1):123–31.PubMedCrossRefGoogle Scholar
  16. Steffen R. Epidemiology of traveler’s diarrhea. Clin Infect Dis. 2005;41 Suppl 8:S536–40.PubMedCrossRefGoogle Scholar
  17. Tsai HC, Lee SS, Liu YC, Lin WR, Huang CK, Chen YS, et al. Clinical manifestations of strongyloidiasis in southern Taiwan. J Microbiol Immunol Infect. 2002;35(1):29–36.PubMedGoogle Scholar
  18. van Nood E, Vrieze A, Nieuwdorp M, Fuentes S, Zoetendal EG, de Vos WM, et al. Duodenal infusion of donor feces for recurrent Clostridium difficile. N Engl J Med. 2013;368(5):407–15.PubMedCrossRefGoogle Scholar
  19. Velazquez FR, Matson DO, Calva JJ, Guerrero L, Morrow AL, Carter-Campbell S, et al. Rotavirus infections in infants as protection against subsequent infections. N Engl J Med. 1996;335(14):1022–8.PubMedCrossRefGoogle Scholar
  20. Wong CS, Jelacic S, Habeeb RL, Watkins SL, Tarr PI. The risk of the hemolytic-uremic syndrome after antibiotic treatment of Escherichia coli O157:H7 infections. N Engl J Med. 2000;342(26):1930–6.PubMedCentralPubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2013

Authors and Affiliations

  • Bonnie P. Youmans
    • 1
  • Nadim J. Ajami
    • 2
  • Sarah K. Highlander
    • 3
  1. 1.Veterinary and Biomedical SciencesUniversity of MinnesotaSaint PaulUSA
  2. 2.Department of Molecular Virology and MicrobiologyCenter for Metagenomics and Microbiome ResearchHoustonUSA
  3. 3.Genomic MedicineJ. Craig Venter InstituteLa JollaUSA